pt-141-peptide-buy-online The search query "psma peptide" indicates a strong interest in the role and applications of peptides associated with Prostate-Specific Membrane Antigen (PSMA). This includes their use in cancer research, diagnostics, and therapeutics, particularly for prostate cancer. The dominant search intent appears to be informational, with users seeking to understand what PSMA peptides are, how they function, and their potential in medical treatments.
PSMA peptides are gaining significant attention in the medical and scientific communities due to their crucial role in targeting Prostate-Specific Membrane Antigen (PSMA)HumanPSMA peptideis a Synthetic blocking peptide. >70% and suitable for BL.. PSMA is a transmembrane protein that is highly expressed on the surface of prostate cancer cells, making it an attractive biomarker for prostate cancer diagnosis, imaging, and targeted therapy. The development of PSMA peptide ligands has opened new avenues for precision medicine, allowing for more effective and less invasive treatment strategies.
Prostate-Specific Membrane Antigen (PSMA) is a glycoprotein that plays a role in various physiological processes, including folate homeostasis. However, its significance in oncology stems from its overexpression in prostate cancer cells, especially in advanced stages and metastatic disease. This elevated expression makes PSMA a prime target for therapeutic interventions and diagnostic imaging. While PSMA is found at low levels in normal tissues like salivary glands and kidneys, its significantly higher concentration in tumors allows for selective targeting. Understanding the difference between PSMA and other related markers, such as PSA (Prostate-Specific Antigen), is crucial for accurate diagnosis and treatment planning.PSMA-targeting peptides. Chemical structures for ...
Peptides, with their small size and high specificity, are ideal candidates for developing PSMA-targeting agents. These peptides can be engineered to bind specifically to PSMA, acting as carriers for diagnostic imaging agents or therapeutic payloads.
* Diagnostic Imaging: PSMA-specific peptides can be radiolabeled and used in Positron Emission Tomography (PET) scans (e.g., PSMA-PET/CT) to detect and stage prostate cancer with high accuracyprostate cancer cells using an RNA/peptide dual-aptamer .... This allows clinicians to visualize tumor locations and assess the extent of the disease more effectively than traditional methods.作者：W Jin·2016·被引用次数：61—Taken together,PSMAis a validated marker for targeted drug delivery to prostate cancer [3,11]. A variety ofPSMA-specific ligands such as ...
* Targeted Therapy: In therapeutic applications, PSMA peptides can be conjugated with radioactive isotopes or cytotoxic drugs.PSMA-Targeted Radiolabeled Peptide for Imaging and ... When these PSMA targeting peptide constructs reach the tumor site, they deliver their payload directly to cancer cells, minimizing damage to healthy tissues. This approach, known as Peptide Receptor Radionuclide Therapy (PRRT), has shown promising results in treating metastatic castration-resistant prostate cancer (mCRPC).
The research into PSMA peptides is rapidly evolving, with several notable advancements:
* Radiolabeled Peptides for Imaging and Therapy: Significant research focuses on developing PSMA-targeted radiolabeled peptides for both diagnostic imaging and therapeutic purposes. These agents can enhance tumor uptake and improve therapeutic efficacyPeptidePool of Human (Prostate-specific membrane antigen) for antigen-specific T cell stimulation. ISO 9001 certfied..
* Peptide-Based Cancer Vaccines: Some research explores peptide-based cancer vaccines that incorporate epitopes related to PSMA, aiming to stimulate the patient's immune system to attack cancer cells.
* Small Molecules and Peptides: The field encompasses both peptide-based ligands and small molecules that target PSMA, offering diverse options for drug development and delivery systems.
* Synthetic Blocking Peptides: In research settings, synthetic Human PSMA peptide can be used as blocking agents to validate antibody binding or to control experimental conditions.
While the potential of PSMA peptides is immense, several factors are critical for their successful application:
* Specificity and Affinity: Ensuring that the PSMA peptide exhibits high specificity for PSMA and strong binding affinity is paramount to avoid off-target effects and maximize therapeutic or diagnostic benefit.
* Synthesis and Production: The efficient synthesis and purification of PSMA peptides, often through solid-phase peptide synthesis (SPPS), are essential for their reliable production.PepTivator® PSMA, human
* Clinical Translation: Moving promising peptide-based agents for cancer treatment from preclinical studies to clinical trials requires rigorous evaluation of safety, efficacy, and pharmacokinetic profiles.
The ongoing development and refinement of PSMA peptide technology hold significant promise for improving the management of prostate cancer, offering more precise diagnostic tools and targeted therapeutic options for patients作者：S Jang·2023—This education exhibit presents the clinical considerations and workflow involved in successful delivery of 177 LuPSMAPRRT..
Join the newsletter to receive news, updates, new products and freebies in your inbox.